Prefilled syringe (PFS)

DEVICE4 trials

Sponsors

UCB BIOSCIENCES, Inc., Eli Lilly and Company, Sandoz

Conditions

HealthyNeovascular Age-related Macular Degeneration (nAMD)

Phase 1

Open-label, Bioequivalence Study of Certolizumab Pegol 200 mg Solution Injected Either by a Prefilled Syringe (Reference) or by an E-Device (Test) in Healthy Subjects

CompletedNCT02806219

UCB BIOSCIENCES, Inc.Healthy

Start: 2016-03-31End: 2016-11-30Updated: 2016-11-17

A Study of Two Formulations of LY3074828 in Healthy Participants

CompletedNCT03662100

Eli Lilly and CompanyHealthy

Start: 2018-09-06End: 2019-01-25Updated: 2024-01-25

A Study of Tirzepatide Administered by Two Different Devices in Healthy Participants

CompletedNCT04004988

Eli Lilly and CompanyHealthy

Start: 2019-08-19End: 2019-12-16Updated: 2023-04-18

Phase 3

Study of the Safety of Use of Intravitreal SOK583A1 Provided in a Prefilled Syringe

CompletedNCT05161806

SandozNeovascular Age-related Macular Degeneration (nAMD)

Start: 2022-03-11End: 2022-05-04Updated: 2022-11-18